CClinicalTrials.gg
Not yet recruitingNCT06514404Updated Jul 23, 2024

Comparative Study of Empathy and Anxiety in the Different Academic Years, at the Beginning of Academic Year and Exam Period in Healthy Students.

An observational study in Health Education, Health Promotion and Health Behavior, sponsored by Mayuben Private Clinic. Not yet recruiting. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-23.

Sponsored by Mayuben Private Clinic · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
65
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Students from different health science degrees will carry out a study on the variables of empathy, anxiety and personality profile.

Read the detailed description

Students from different health science degrees will carry out a study on the variables of empathy, anxiety and personality profile by means of validated questionnaires in order to compare them between different Spanish regions and in different courses to be able to see their evolution and characteristics.

02

Conditions studied

  • Health Education
  • Health Promotion
  • Health Behavior

Keywords

  • health students
  • anxiety
  • empahty
  • assessment personality
  • Health behavior
03

In context

Lead sponsor

Mayuben Private Clinic is the lead sponsor of 21 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Health science students are the target population of this study and the aim is to obtain data on their state and trait anxiety as well as its relationship with personality at the beginning of the academic year.

Inclusion criteria

  • Men and women who are studying a health grade.
  • Subjects that wish to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Students who do not wish to participate in the study.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
65 participants (estimated)
Patient registry
No

Interventions

  • Otherobservational study

    Observational study of the effects on anxiety and empathy of personality the situation of start academic year in health sciences

06

What researchers measure

Primary outcomes

  1. Empathy Quotent

    It consists of 60 items, 40 measuring empathy and 20 control measures. Scores range from 0 to 80. It measures cognitive and affective empathy in adults. Equalizer allows classification into four categories, which facilitates comparison between groups. The cut-off for each level is: from 0 to 32 scores: low empathy (average scores in Asperger Syndrome is 20), from 33 to 52 scores: average empathy (average in men 42, average in women 47), from 53 to 63 scores: above average, from 64 to 80 scores: high empathy

    Time frame: Through study completion, an average of 1 week

  2. State anxiety

    The response scale is Likert-type with 4 alternatives (in the Spanish adaptation from 0 to 3). There are 20 items for evaluation. Thus, the range of responses goes from 0 to 60, with a higher level of anxiety corresponding to a higher score.

    Time frame: Through study completion, an average of 1 week

  3. Anxiety as a trait

    The response scale is Likert-type with 4 alternatives (in the Spanish adaptation from 0 to 3). Trait anxiety has 20 items for its evaluation. Thus, the range of responses goes from 0 to 60, with a higher level of anxiety corresponding to a higher score.

    Time frame: Through study completion, an average of 1 week

  4. Abbreviated personality questionnaire

    The EPQR-A is an abbreviated form of the Eysenck Personality Questionnaire. It is a 24-item self-report measure that leverages three personality scales (extraversion, neuroticism and psychoticism) and a lie validity scale. Each scale is assessed by 6 questions that participants rate on a binary frequency scale scored 1 or 0.

    Time frame: Through study completion, an average of 1 week

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06514404
Lead sponsor
Mayuben Private Clinic
Responsible party
EVA MARIA MARTÍNEZ JIMENEZ (Profesor, Universidad Complutense de Madrid) — Principal investigator
First posted
Jul 23, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Sep 6, 2024 (estimated)
Completion
Sep 10, 2024 (estimated)
Last update
Jul 23, 2024

Study contacts

Eva María Martínez-Jiménez, PhD
Contact
evamam03@ucm.es
913941498

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion